Ibotta (IBTA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IBTA SEC filings page.
Ibotta (IBTA) reported $343.2M in revenue over the twelve months to Jun 30, 2026, down 6.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
High gross margins gave way to a 2025 profitability reset as weaker revenue and heavier operating costs reshaped cash economics.
FY2025 operating cash flow reached$95M against only$4M of net income, so accounting earnings understated cash generation materially. With free cash flow at$75M after$20M of capital spending, the business remained cash-generative even as operating profit slipped below zero, showing that reported profit and cash were being shaped by different items.
FY2025 revenue fell to
The $233M buyback exceeded FY2025’s
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Ibotta's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Ibotta has an operating margin of -0.3%, meaning the company loses less than $1 on every $100 of revenue. This results in a profitability score of 39/100. This is down from 7.6% the prior year.
Ibotta's revenue declined 6.8% year-over-year, from $367.3M to $342.4M. This contraction results in a growth score of 43/100.
Ibotta carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Ibotta's current ratio of 1.96 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.
Ibotta converts 21.9% of revenue into free cash flow ($75.0M). This strong cash generation earns a score of 88/100.
Ibotta's ROE of 1.2% shows moderate profitability relative to equity, earning a score of 58/100. This is down from 15.0% the prior year.
Ibotta scores 3.09, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($932.8M) relative to total liabilities ($238.3M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Ibotta passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
Ibotta reported $3.6M of net income while generating $95.3M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.
Ibotta reported an operating loss of $841K against $500K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Ibotta generated $88.9M in revenue in Q2 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is up 7.8%.
Ibotta's EBITDA was $1.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 59.4% from the same quarter a year earlier. Against the prior quarter it is up 118.8%.
Ibotta reported -$1.2M in net income in Q2 2026. This represents a decrease of 149.4% from the same quarter a year earlier. Against the prior quarter it is up 88.1%.
Ibotta earned -$0.05 per diluted share (EPS) in Q2 2026. This represents a decrease of 162.5% from the same quarter a year earlier. Against the prior quarter it is up 88.4%.
Cash & Balance Sheet
Ibotta generated $12.4M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 44.4% from the same quarter a year earlier. Against the prior quarter it is down 54.7%.
Ibotta held $148.2M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Ibotta's gross margin was 78.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.
Ibotta's operating margin was -2.1% in Q2 2026, reflecting core business profitability. This is down 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.0 percentage points.
Ibotta's net profit margin was -1.4% in Q2 2026, showing the share of revenue converted to profit. This is down 4.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.1 percentage points.
Ibotta's ROE was -0.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.6 percentage points.
Capital Allocation
Ibotta invested $15.1M in research and development in Q2 2026. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 3.9%.
Ibotta spent $26.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 63.1% from the same quarter a year earlier. Against the prior quarter it is down 42.1%.
Ibotta invested $890K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 75.5% from the same quarter a year earlier. Against the prior quarter it is down 71.0%.
IBTA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.9M+3.3% | $82.5M-2.5% | $88.5M-10.0% | $83.3M-15.6% | $86.0M-2.2% | $84.6M+2.7% | $98.4M-1.3% | $98.6M+15.6% |
| Cost of Revenue | $19.2M+7.0% | $19.4M+13.8% | $18.9M+24.7% | $17.1M+40.8% | $17.9M+45.9% | $17.1M+62.5% | $15.2M+23.0% | $12.2M+12.9% |
| Gross Profit | $69.7M+2.4% | $63.0M-6.6% | $69.6M-16.3% | $66.1M-23.5% | $68.1M-10.0% | $67.5M-6.0% | $83.2M-4.7% | $86.4M+16.0% |
| R&D Expenses | $15.1M+2.2% | $14.5M-19.7% | $14.2M-9.9% | $14.0M-13.9% | $14.7M-15.9% | $18.1M+32.5% | $15.8M+15.6% | $16.3M+31.4% |
| SG&A Expenses | $21.8M-2.1% | $23.8M+11.1% | $22.1M+9.3% | $22.5M+8.9% | $22.3M-22.4% | $21.4M+62.6% | $20.2M+50.5% | $20.6M+70.4% |
| Operating Income | -$1.9M-251.6% | -$10.8M-286.4% | -$1.6M-112.7% | $2.4M-88.6% | $1.2M+105.7% | -$2.8M-117.6% | $13.0M-50.6% | $20.7M+90.5% |
| EBITDA | $1.5M-59.4% | -$8.0M-1147.8% | $825K-94.5% | $3.6M-84.2% | $3.7M+118.8% | -$638K-103.6% | $14.9M-45.2% | $22.8M+70.9% |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | $61K-97.8% | $39K-98.1% |
| Income Tax | $697K-49.4% | $969K+1445.8% | $1.2M+102.1% | $3.7M-52.9% | $1.4M-65.0% | -$72K-102.3% | -$59.2M-1704.4% | $7.9M+1393.1% |
| Net Income | -$1.2M-149.4% | -$10.3M-1959.8% | -$998K-101.3% | $1.5M-91.1% | $2.5M+107.3% | $555K-94.0% | $76.2M+308.5% | $17.2M+104.9% |
| EPS (Basic) | -$0.05-155.6% | -$0.43-2250.0% | -$0.03-100.9% | $0.05-91.1% | $0.09+106.8% | $0.02-98.0% | $3.19+54.1% | $0.56-40.4% |
| EPS (Diluted) | -$0.05-162.5% | -$0.43-2250.0% | -$0.03-101.0% | $0.05-90.2% | $0.08+106.1% | $0.02-93.9% | $2.90+320.3% | $0.51+64.5% |
| Diluted Shares (Avg) | 23M-23.5% | 24M-27.3% | N/A | 29M-12.5% | 30M+18.6% | 33M+17.1% | N/A | 34M+25.1% |
IBTA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $485.4M-19.2% | $479.9M-24.9% | $525.9M-22.5% | $569.4M-4.8% | $600.8M+8.0% | $639.3M+98.5% | $678.4M+112.1% | $598.3M |
| Current Assets | $365.6M-24.2% | $361.0M-31.6% | $407.9M-29.9% | $455.5M-20.9% | $482.6M-9.7% | $528.0M+75.9% | $581.7M+95.0% | $576.1M |
| Cash & Equivalents | $148.2M-40.9% | $164.6M-44.6% | $186.6M-46.6% | $223.3M-34.6% | $250.5M-21.2% | $297.1M+273.7% | $349.3M+458.0% | $341.3M+760.2% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $203.4M-2.7% | $183.1M-11.2% | $208.7M-5.5% | $212.8M-6.6% | $209.0M0.0% | $206.2M-0.1% | $220.9M-2.5% | $227.8M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $243.8M-1.1% | $230.9M-3.0% | $238.3M+7.7% | $239.8M+8.9% | $246.7M+25.6% | $238.0M-14.4% | $221.1M-24.2% | $220.3M |
| Current Liabilities | $213.5M+4.6% | $200.9M+2.2% | $207.8M+1.8% | $206.5M-2.3% | $204.0M+7.3% | $196.5M+8.2% | $204.2M+3.0% | $211.5M |
| Non-Current Liabilities | $30.4M-28.8% | $30.0M-27.6% | $30.5M+79.6% | $33.3M+276.9% | $42.6M+589.4% | $41.5M-56.9% | $17.0M-81.9% | $8.8M |
| Long-Term Debt | N/A | N/A | $0 | N/A | N/A | N/A | $0-100.0% | $0 |
| Total Equity | $241.6M-31.8% | $249.0M-38.0% | $287.7M-37.1% | $329.6M-12.8% | $354.1M-1.5% | $401.3M+810.0% | $457.3M+1537.4% | $378.0M+29590.3% |
| Retained Earnings | -$148.4M-8.0% | -$147.2M-5.2% | -$136.9M+2.5% | -$135.9M+37.3% | -$137.4M+41.2% | -$139.9M+30.0% | -$140.4M+32.9% | -$216.6M |
Not reported in any period shown, so not listed: Inventory, Goodwill.
IBTA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.3M-48.7% | $30.4M+52.9% | $27.8M+26.5% | $21.8M-45.0% | $25.9M-26.2% | $19.9M+2.6% | $22.0M-7.1% | $39.5M+2054.7% |
| Depreciation & Amortization | $3.4M+38.0% | $2.9M+32.6% | $2.5M+28.5% | $1.2M-41.8% | $2.4M+15.7% | $2.2M+13.4% | $1.9M+109.8% | $2.1M-14.3% |
| Stock-Based Compensation | $15.0M+10.3% | $14.5M+25.3% | N/A | $12.6M-7.7% | $13.6M-69.6% | $11.6M+539.0% | N/A | $13.7M+26.9% |
| Capital Expenditures | $890K-75.5% | $3.1M+62.0% | $7.5M+3383.8% | $7.2M+2300.0% | $3.6M+1704.0% | $1.9M+1146.1% | $216K+22.7% | $302K+77.6% |
| Free Cash Flow | $12.4M-44.4% | $27.3M+52.0% | $20.3M-6.8% | $14.5M-63.0% | $22.2M-36.2% | $18.0M-6.5% | $21.8M-7.3% | $39.2M+1889.4% |
| Investing Cash Flow | -$5.2M+25.7% | -$7.1M-42.1% | -$11.2M-339.1% | -$11.2M-289.3% | -$7.0M-201.5% | -$5.0M-101.4% | -$2.5M-28.2% | -$2.9M-15.6% |
| Financing Cash Flow | -$24.5M+62.8% | -$45.3M+32.4% | -$53.4M-384.1% | -$37.8M-185.4% | -$65.8M-132.0% | -$67.0M-745088.9% | -$11.0M-992.8% | -$13.3M-2868.5% |
| Share Buybacks | $26.0M-63.1% | $44.8M-35.8% | $54.8M+248.8% | $38.0M+143.4% | $70.4M | $69.8M | $15.7M | $15.6M |
Not reported in any period shown, so not listed: Dividends Paid.
IBTA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.4%-0.7pp | 76.4%-3.4pp | 78.6%-5.9pp | 79.4%-8.3pp | 79.2%-6.9pp | 79.8%-7.4pp | 84.6%-3.0pp | 87.7%+0.3pp |
| Operating Margin | -2.1%-3.6pp | -13.1%-9.8pp | -1.8%-15.0pp | 2.8%-18.2pp | 1.4%+26.1pp | -3.3%-22.6pp | 13.2%-13.2pp | 21.0%+8.2pp |
| Net Margin | -1.4%-4.3pp | -12.5%-13.2pp | -1.1%-78.5pp | 1.8%-15.6pp | 2.9%+41.5pp | 0.7%-10.6pp | 77.4%+58.7pp | 17.5%+7.6pp |
| Return on Equity | -0.5%-1.2pp | -4.2%-4.3pp | -0.3%-17.0pp | 0.5%-4.1pp | 0.7%+10.1pp | 0.1%-20.9pp | 16.7%-50.1pp | 4.6%-656.3pp |
| Return on Assets | -0.3%-0.7pp | -2.1%-2.2pp | -0.2%-11.4pp | 0.3%-2.6pp | 0.4%+6.5pp | 0.1%-2.8pp | 11.2%+5.4pp | 2.9% |
| Current Ratio | 1.71-0.7x | 1.80-0.9x | 1.96-0.9x | 2.21-0.5x | 2.37-0.4x | 2.69+1.0x | 2.85+1.3x | 2.72 |
| Debt-to-Equity | 1.01+0.3x | 0.93+0.3x | 0.000.0x | 0.73+0.7x | 0.70+0.7x | 0.59-0.9x | 0.00-2.3x | 0.00 |
| Asset Turnover | 0.180.0x | 0.170.0x | 0.170.0x | 0.150.0x | 0.140.0x | 0.13-0.1x | 0.14-0.2x | 0.16 |
| FCF Margin | 13.9%-11.9pp | 33.1%+11.9pp | 22.9%+0.8pp | 17.4%-22.4pp | 25.8%-13.8pp | 21.2%-2.1pp | 22.1%-1.4pp | 39.8%+42.4pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Ibotta IBTA | FY2025 | $342.4M | $3.6M | 1.1% | $932.8M | 64/100 |
| Viant Technology Inc. DSP | FY2025 | $344.2M | $8.4M | 2.4% | $284.9M | 67/100 |
| Riskified Ltd RSKD | FY2025 | $344.6M | -$27.6M | -8.0% | $813.4M | 56/100 |
| VTEX VTEX | FY2025 | $240.5M | $20.0M | 8.3% | $585.3M | 58/100 |
| Pros Holdings PRO | FY2024 | $330.4M | -$20.5M | -6.2% | $1.1B | 32/100 |
| Ribbon Communications RBBN | FY2025 | $844.6M | $40K | 0.0% | $347.8M | 31/100 |
Where Ibotta Ranks
Frequently Asked Questions
What is Ibotta's annual revenue?
Ibotta (IBTA) reported $342.4M in total revenue for fiscal year 2025. This represents a -6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Ibotta's revenue growing?
Ibotta (IBTA) revenue declined by 6.8% year-over-year, from $367.3M to $342.4M in fiscal year 2025.
Is Ibotta profitable?
Yes, Ibotta (IBTA) reported a net income of $3.6M in fiscal year 2025, with a net profit margin of 1.1%.
What is Ibotta's EBITDA?
Ibotta (IBTA) had EBITDA of $7.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Ibotta have?
As of fiscal year 2025, Ibotta (IBTA) had $186.6M in cash and equivalents against $0 in long-term debt.
What is Ibotta's gross margin?
Ibotta (IBTA) had a gross margin of 79.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Ibotta's operating margin?
Ibotta (IBTA) had an operating margin of -0.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ibotta's net profit margin?
Ibotta (IBTA) had a net profit margin of 1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ibotta's return on equity (ROE)?
Ibotta (IBTA) has a return on equity of 1.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Ibotta's free cash flow?
Ibotta (IBTA) generated $75.0M in free cash flow during fiscal year 2025. This represents a -34.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Ibotta's operating cash flow?
Ibotta (IBTA) generated $95.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Ibotta's total assets?
Ibotta (IBTA) had $525.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Ibotta's capital expenditures?
Ibotta (IBTA) invested $20.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Ibotta spend on research and development?
Ibotta (IBTA) invested $61.1M in research and development during fiscal year 2025.
What is Ibotta's current ratio?
Ibotta (IBTA) had a current ratio of 1.96 as of fiscal year 2025, which is generally considered healthy.
What is Ibotta's debt-to-equity ratio?
Ibotta (IBTA) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ibotta's return on assets (ROA)?
Ibotta (IBTA) had a return on assets of 0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ibotta's P/E ratio?
Ibotta (IBTA) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $932.8M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ibotta's price-to-sales ratio?
Ibotta (IBTA) trades at 2.7x sales, its market capitalization divided by revenue of $343.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $932.8M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ibotta's Altman Z-Score?
Ibotta (IBTA) has an Altman Z-Score of 3.09, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Ibotta's Piotroski F-Score?
Ibotta (IBTA) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ibotta's earnings high quality?
Ibotta (IBTA) reported $3.6M of net income while generating $95.3M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ibotta cover its interest payments?
Ibotta (IBTA) reported an operating loss of $841K against $500K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Ibotta?
Ibotta (IBTA) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.